menu
    • menu

    Company profile for Apontis Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At APONTIS PHARMA, our ethos is embodied in our name. We are facilitators, connecting doctors, patients, partners, and health institutions. Our primary goal is superior patient care. Understanding the needs of patients with chronic illnesses, we develop innovative combination products to make Single Pill therapy accessible to more patients. Alongside our pharmaceutical offerings, we provide tailored consulting services and tra...
    At APONTIS PHARMA, our ethos is embodied in our name. We are facilitators, connecting doctors, patients, partners, and health institutions. Our primary goal is superior patient care. Understanding the needs of patients with chronic illnesses, we develop innovative combination products to make Single Pill therapy accessible to more patients. Alongside our pharmaceutical offerings, we provide tailored consulting services and training for physicians. Our dedicated consultants forge strong relationships with physicians, offering ongoing support. Our culture is built on mutual respect, honesty, and a commitment to personal accountability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apontis PharmaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Alfred-Nobel-Str. 10, 40789 Monheim
    Telephone
    Telephone
    +49 2173484949
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://apontis-pharma.de/en/about-apontis-pharma
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apontis-pharma/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apontis Pharma: Management Board Changes
    Apontis Pharma: Management Board Changes

    20 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-20/apontis-pharma-changes-in-the-management-board

    PHARMAWEB
    20 Aug 2025
    Share Share
    Zentiva Acquires 85.27% Voting Rights in APONTIS PHARMA
    Zentiva Acquires 85.27% Voting Rights in APONTIS PHARMA

    26 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zentiva-secures-approx-85-27-of-apontis-pharma-ag-voting-rights-in-the-context-of-its-public-purchase-offer-302316398.html

    PR NEWSWIRE
    26 Nov 2024
    Share Share
    Apontis Pharma Waives Minimum Acceptance in Zentiva’s Purchase Offer
    Apontis Pharma Waives Minimum Acceptance in Zentiva’s Purchase Offer

    21 Nov 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-11-21/apontis-pharma-ag-condition-of-minimum-acceptance-in-zentiva-s-voluntary-public-purchase-offer-waiv

    PHARMAWEB
    21 Nov 2024
    Share Share
    APONTIS PHARMA starts financial year 2024 with growth in revenue
    APONTIS PHARMA starts financial year 2024 with growth in revenue

    08 May 2024

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2024-05-08/apontis-pharma-starts-financial-year-2024-with-growth-in-revenue-of-single-pill-combinations-and-pos

    PHARMIWEB
    08 May 2024
    Share Share
    New development partnership with Apontis Pharma
    New development partnership with Apontis Pharma

    12 Dec 2023

    // PRESS RELEASE

    https://www.midas-pharma.com/en/latest-activities/new-development-partnership-with-apontis-pharma/

    PRESS RELEASE
    12 Dec 2023
    Share Share
    APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan
    APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan

    19 Jul 2022

    // PRESS RELEASE

    https://www.midas-pharma.com/en/latest-activities/apontis-pharma-and-midas-pharma-agree-on-further-development-partnership/

    PRESS RELEASE
    19 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search